Keystone Labs Keeps OTC Drugs In Plans After Court Orders Manufacturing Halt
Keystone Labs agrees to cease manufacturing OTC drugs after repeat GMP violations following a 2013 FDA warning letter, including failure to investigate sources of contamination. Firm says it informed FDA it would outsource OTC product manufacturing and continue making hair and skin care cosmetic formulas.
You may also be interested in...
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
New studies from Chanel researchers and Gettysburg College support makeup’s anti-aging effect. More news in brief.
Colgate agrees to purchase Hello Products direct-to-consumer oral care brand, complementing its Colgate brand and its Tom’s of Maine natural-positioned line. The firm will pay with a combination of cash and debt in the deal expected to close no later than the end of February.